Daiwa Pharmaceutical Co. (Japan)

513 papers and 12.3k indexed citations i.

About

In recent decades, authors affiliated with Daiwa Pharmaceutical Co. (Japan) have published 513 papers, which have received a total of 12.3k indexed citations. Scholars at this organization have produced 214 papers in Molecular Biology, 175 papers in Pharmacology and 128 papers in Organic Chemistry on the topics of Microbial Natural Products and Biosynthesis (115 papers), Fungal Biology and Applications (35 papers) and Antibiotics Pharmacokinetics and Efficacy (35 papers). Their work is cited by papers focused on Molecular Biology (6.1k citations), Organic Chemistry (3.6k citations) and Pharmacology (3.3k citations). Authors at Daiwa Pharmaceutical Co. (Japan) collaborate with scholars in Japan, United Kingdom and New Zealand and have published in prestigious journals including Food Chemistry, Molecules and Organic Letters. Some of Daiwa Pharmaceutical Co. (Japan)'s most productive authors include MASANOBU KOHSAKA, MASAKUNI OKUHARA, HATSUO AOKI, Hiroshi Imanaka, Toshio Goto, Hiroshi Terano, Heiichi Sakai, Hiroshi Hatanaka, Toru Kino and Michihisa Nishiyama.

In The Last Decade

Fields of papers published by authors at Daiwa Pharmaceutical Co. (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Daiwa Pharmaceutical Co. (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Daiwa Pharmaceutical Co. (Japan) at the time of their publication.

Countries citing scholars working at Daiwa Pharmaceutical Co. (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Daiwa Pharmaceutical Co. (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Daiwa Pharmaceutical Co. (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiwa Pharmaceutical Co. (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025